df176ce612
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
3.9 KiB
3.9 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. | reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. | us/states/sd | South Dakota Legislature | 2026 | HB 1099 | South Dakota HB 1099 (2026) |
|
|
enacted |
|
2 | 14 | 4 | 2026-01-21 | 2026-03-10 | openstates | ocd-bill/0e6db9e8-e382-4100-b698-bf00e9cd3edf | https://sdlegislature.gov/Session/Bill/26592 | 628928e80c54eeefd5e3796484e770f95a1dcd24852378197d4b8e0c942ee0d1 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
South Dakota HB 1099 (2026) — reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Do Pass — 6–0 (pass) · upper
- Do Pass — 21–12 (pass) · upper
- Do Pass — 58–7 (pass) · lower
- Do Pass — 13–0 (pass) · lower
Sponsors
- Davis — primary (person)
- Emery — primary (person)
- Goodwin — primary (person)
- Heermann — primary (person)
- Moore — primary (person)
- Muckey — primary (person)
- Mulder — primary (person)
- Perry — primary (person)
- Pischke — primary (person)
- Rehfeldt — primary (person)
- Uhre-Balk — primary (person)
- Wipf — primary (person)
- Wittman — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-21 First read in House and referred to House Health and Human Services H.J. 104
introduction, reading-1, referral-committee - 2026-02-05 Scheduled for hearing H.J. 1
- 2026-02-05 Health and Human Services Do Pass , Passed, YEAS 13, NAYS 0 H.J. 13
committee-passage - 2026-02-09 House of Representatives Do Pass , Passed, YEAS 58, NAYS 7 H.J. 265
passage - 2026-02-10 First read in Senate and referred to Senate Health and Human Services S.J. 232
introduction, reading-1, referral-committee - 2026-02-25 Scheduled for hearing S.J. 1
- 2026-02-25 Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 21
committee-passage - 2026-02-25 Certified uncontested, placed on consent , Passed, S.J. 21
- 2026-02-26 Remove from Consent Calendar S.J. 412
- 2026-03-02 Senate Do Pass , Passed, YEAS 21, NAYS 12 S.J. 429
passage - 2026-03-03 Signed by the Speaker H.J. 492
passage - 2026-03-04 Signed by the President S.J. 470
passage - 2026-03-05 Delivered to the Governor on 2026-03-05 H.J. 520
executive-receipt - 2026-03-10 Signed by the Governor on 2026-03-10 H.J. 547
executive-signature, executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/0e6db9e8-e382-4100-b698-bf00e9cd3edf. Confidence: reported (aggregated from official South Dakota legislature records).